Strategic Plan

Indian mother and child
February 11, 2016

Slight chemical change may improve TB treatments: study

One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.

By Leigh MacMillan
February 11, 2016

Study identifies potential colon cancer biomarker

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.

By Bill Snyder
older man
February 4, 2016

Prostate cancer survivors’ risk of heart disease studied

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

By Kathy Whitney
February 4, 2016

VICC joins other major cancer centers in HPV vaccine campaign

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.

By VUMC News and Communications
eye
February 4, 2016

Grant spurs research into trauma-induced vision loss

Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide.

By Jessica Pasley
February 1, 2016

Successful entrepreneur and innovator chosen to lead new Innovation Center

Startup veteran Robert Grajewski has been chosen as the inaugural executive director of the newly created Vanderbilt University Innovation Center.

By VUMC News and Communications
January 28, 2016

Findings offer new insight on how cell division proteins work

A family of proteins with critical roles in cell division, synaptic transmission and cell migration don’t all function the way scientists thought they did, according to two new studies led by Vanderbilt researchers.
By Leigh MacMillan
January 28, 2016

Cochlear implant’s success is music to patient’s ears

Sidney Kleinman is living proof that you’re never too old to have your hearing restored.
By Matt Batcheldor
January 28, 2016

Autism study links sensory difficulties, serotonin system

Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD.
By VUMC News and Communications
January 25, 2016

Using MRI to assess myelin health

Vanderbilt investigators report an improved model for estimating brain health, using MRI.
By Sanjay Mishra
January 22, 2016

Faulty building blocks in DNA

An enzyme that builds DNA is able to insert the wrong building blocks, which could generate mutations.
By Bill Snyder
January 21, 2016

Antibodies may be ‘silver bullet’ for Ebola viruses

There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.
By Bill Snyder
January 21, 2016

New targets for diabetic retinopathy

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.
By VUMC News and Communications
1 … 5 6 7 8 9 … 16